Discover why HPV vaccination rates lag behind despite preventing cervical cancer. Learn the facts about this life-saving vaccine and why hesitation persists.

Her name is Scholastica Stambuli, a vibrant youth advocate whose journey from a concerned citizen to a community health ...

Kong told MedPage Today that previous research has found that vaccine uptake and completion varies by race and ethnicity, ...

One of the most effective vaccines available was going to become more accessible—until RFK Jr. dismissed the CDC’s advisory ...

The Atlantic Daily, a newsletter that guides you through the biggest stories of the day, helps you discover new ideas, and recommends the best in culture. Sign up for it here. Until last week, the ...

The HPV vaccine, recommended from age 9, offers long-term protection against multiple cancers and infections, making early vaccination crucial for both girls and boys.

Human papillomavirus (HPV) vaccines play a central role in the prevention of HPV-related cancers, including cervical, oropharyngeal, anal, and genital cancers.

The global Human Papillomavirus (HPV) Vaccines market, valued at USD 5.5 billion in 2024, is anticipated to grow to USD 9.7 billion by 2030 at a CAGR ...

Kennedy’s decision to replace ACIP wholesale and the comments he has made about deviating from standard vaccine policymaking ...

Girls aged 9 to 14 years old in this city's schools are encouraged to avail of the first dose of the free anti-human ...

Developed in collaboration with the Department of Biotechnology, the vaccine covers HPV types 6, 11, 16, and 18 and is recommended for both males and females aged 9–26 years.